D. Plotkin

Statistics

Publications

Citations

777

H-Index

Active since

1973

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Radiant Research (United States)

National Research Institute

Louisville Metabolic and Atherosclerosis Research Center

University of California, Los Angeles

D. Plotkin is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, clinical pharmacology, and pharmacotherapy.

Publications per year

1973–2016

Publications

Effects of an 11 <i>β</i> ‐hydroxysteroid dehydrogenase type 1 inhibitor, MK‐0916, in patients with type 2 diabetes mellitus and metabolic syndrome

P. U. Feig, Sukrut Shah, Anne Hermanowski‐Vosatka et al. · Diabetes Obesity and Metabolism · 2011 · 159 citations

Medicine, Endocrinology, Pharmacology +17

Are Performance-Based Measures Sufficiently Reliable for Use in Multicenter Trials?

Alan M. Jette, Diane U. Jette, Jennifer Ng et al. · The Journals of Gerontology Series A · 1999 · 146 citations

Medicine, Geriatric Medicine, Rehabilitation Medicine +17

Effect of Cholesterol-Lowering Therapy on Coronary Endothelial Vasomotor Function in Patients With Coronary Artery Disease

Joseph A. Vita, Alan C. Yeung, Michael D. Winniford et al. · Circulation · 2000 · 120 citations

Medicine, Cardiology, Pharmacology +17

Efficacy and safety of ezetimibe co‐administered with simvastatin in thiazolidinedione‐treated type 2 diabetic patients

Linda Gaudiani, Alex Lewin, Luigi Meneghini et al. · Diabetes Obesity and Metabolism · 2004 · 74 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Oral Administration of the Growth Hormone Secretagogue MK-677 Increases Markers of Bone Turnover in Healthy and Functionally Impaired Elderly Adults

M. Gail Murphy, Mark A. Bach, D. Plotkin et al. · Journal of Bone and Mineral Research · 1999 · 49 citations · Full text

Medicine, Endocrinology, Geriatric Medicine +17

1–5 of 12